Is JXN a Buy? What to Consider in 2026
Last updated July 2026
Short answer
The bull case for Jackson Financial (JXN) rests on Record annuity sales momentum: Retail annuity sales hit a record of about $19.7 billion in 2025, up roughly 10%, and Q1 2026 retail annuity sales of about $5.3 billion were up 31% year over year. 2025 adjusted operating EPS is ~$22.67. If you believe that thesis holds, the real questions become position sizing and overlap, not timing. The main risk to that view: GAAP earnings are highly volatile because of market risk benefit accounting, hedging outcomes, and reinsured business, and the company reported a small GAAP net loss to common shareholders in 2025 even as operating earnings rose. Whether JXN is a buy comes down to whether you believe the thesis. This is informational, not a recommendation, and Walnut is not an investment adviser.
Jackson Financial (NYSE: JXN) is one of the largest sellers of annuities in the United States, focused on retirement-income products such as variable annuities, registered index-linked annuities (RILAs), and fixed and fixed index annuities distributed through independent advisors and broker-dealers. The company became a standalone public company in 2021 after separating from the UK's Prudential plc, and its core business is collecting premiums, managing the associated market and longevity risk (partly through hedging and reinsurance), and paying out retirement income over time. The investment picture centers on capital return and valuation rather than smooth accounting earnings. JXN generates large amounts of statutory cash that it returns to shareholders through a growing dividend and sizable buybacks, and it has historically traded below book value with a low forward multiple. The tradeoff is that GAAP net income can swing dramatically (even to a loss) because of market risk benefit accounting, hedging results, and reinsured business, so the stock appeals to investors comfortable with insurance complexity and volatility in exchange for yield and a discounted valuation.
What's the case for buying JXN?
1. Record annuity sales momentum
Retail annuity sales hit a record of about $19.7 billion in 2025, up roughly 10%, and Q1 2026 retail annuity sales of about $5.3 billion were up 31% year over year. Growth has been led by registered index-linked annuities (RILAs) and a surge in fixed and fixed index annuity volume, broadening the product mix beyond traditional variable annuities.
2. Aggressive capital returns
Jackson returned about $862 million to common shareholders in 2025 and raised its quarterly dividend 12.5% to $0.90 per share. Management set a 2026 capital-return target of roughly $900 million to $1.1 billion, so a meaningful part of the thesis rests on continued dividends plus buybacks shrinking the share count.
3. Below-book valuation and low multiple
The stock has traded around 0.86x price-to-book and at a low single-digit forward earnings multiple, reflecting both the discount insurers often carry and the market's skepticism about volatile results. If capital generation stays strong, that discount is the main source of potential re-rating.
4. Demographic tailwind for retirement income
An aging US population and demand for principal protection with market participation support structural demand for RILAs and fixed index annuities. Jackson's large distribution footprint and product breadth position it to capture that flow as more workers convert savings into guaranteed or protected income.
What are the risks to JXN?
GAAP earnings are highly volatile because of market risk benefit accounting, hedging outcomes, and reinsured business, and the company reported a small GAAP net loss to common shareholders in 2025 even as operating earnings rose. Results are sensitive to equity markets, interest rates, and policyholder behavior, and a sharp downturn could pressure hedging costs and statutory capital. The reliance on variable and index-linked annuities concentrates risk in market-linked products, and heavy capital returns leave less cushion if conditions deteriorate. Regulatory and reinsurance-related developments could also affect reported capital and future payouts.
How is JXN valued? (as of JULY 2026)
Snapshot for JXN as of July 2026, sourced from Yahoo Finance and may be delayed. Valuation figures move with price and earnings; verify the current numbers with your broker before deciding.
- Market cap: ~$7.8B
- 2025 adjusted operating EPS: ~$22.67
- Q1 2026 adjusted operating EPS (ex notable items): ~$5.94
- Annual dividend / yield: ~$3.60 (~3.3%)
- Price / book: ~0.86x
- 2025 retail annuity sales: ~$19.7B
JXN trades below book value with a low forward earnings multiple, a pattern common for annuity insurers whose GAAP results swing with markets and hedging. Adjusted operating earnings grew in 2025 and into Q1 2026 even though GAAP net income to common shareholders was a small loss for full-year 2025. The valuation and yield largely reflect the company's cash generation and capital-return program rather than smooth reported profit.
How do you decide if JXN is a buy?
Rather than asking whether JXN is a buy in the abstract, it tends to help to answer four questions:
- Thesis: do you believe the case above, and is it still true today?
- Time horizon: a single stock can be volatile, so a longer horizon absorbs more of the swings.
- Position sizing: a thesis can be right and the sizing still wrong; decide how much of your portfolio one name should be.
- Overlap: check whether you already hold JXN indirectly through an index or sector ETF before adding more.
For the full picture, see the JXN stock guide (what the company does, the ETFs that hold it, similar stocks, and the themes it fits). In Walnut you can ask its AI about JXN against your real portfolio and see your actual exposure before deciding.
The bottom line on JXN
The bottom line: Jackson Financial's story right now is Record annuity sales momentum, with 2025 adjusted operating eps at ~$22.67. If you believe that narrative continues, the call is about sizing JXN sensibly and checking overlap with what you own; if you doubt it (the risk: gAAP earnings are highly volatile because of market risk benefit accounting, hedging outcomes, and reinsured business, and the company reported a small GAAP net loss to common shareholders in 2025 even as operating earnings rose.), it is not for you. Decide from the thesis, not the ticker. Walnut is not an investment adviser.
Build a basket around JXN with Walnut
Use Jackson Financial as one constituent in a thematic basket Walnut's AI helps you assemble. Describe a thesis you believe in, the AI proposes the holdings and weights, and you approve before any broker order.
FAQ
Is JXN a good stock to buy right now?
+
The case for Jackson Financial right now is Record annuity sales momentum, with 2025 adjusted operating eps at ~$22.67. If you believe that thesis holds, JXN is a way to own it and the real questions are sizing and overlap, not timing; the main risk to that view is gAAP earnings are highly volatile because of market risk benefit accounting, hedging outcomes, and reinsured business, and the company reported a small GAAP net loss to common shareholders in 2025 even as operating earnings rose. So it comes down to whether you believe the thesis. Walnut is not an investment adviser and this is not a recommendation.
What does Jackson Financial do?
+
Jackson Financial (NYSE: JXN) is one of the largest sellers of annuities in the United States, focused on retirement-income products such as variable annuities, registered index-li
What are the main risks of JXN?
+
GAAP earnings are highly volatile because of market risk benefit accounting, hedging outcomes, and reinsured business, and the company reported a small GAAP net loss to common shareholders in 2025 even as operating earnings rose. Results are sensitive to equity markets, interest rates, and policyholder behavior, and a sharp downturn could pressure hedging costs and statutory capital. The reliance on variable and index-linked annuities concentrates risk in market-linked products, and heavy capital returns leave less cushion if conditions deteriorate. Regulatory and reinsurance-related developments could also affect reported capital and future payouts.
What does Jackson Financial (JXN) do?
+
Jackson Financial is a US insurer that sells annuities and retirement-income products, including variable annuities, registered index-linked annuities (RILAs), and fixed and fixed index annuities. It collects premiums, manages the associated market and longevity risk, and pays out income to retirees over time.
Is JXN a good dividend stock?
+
JXN pays an annual dividend of about $3.60 per share for a yield near 3.3% as of JULY 2026, and it raised the payout 12.5% in early 2026. Whether that suits you depends on your income goals and tolerance for insurance-sector volatility. Walnut is not an investment adviser.
Why does JXN trade below book value?
+
As of JULY 2026 JXN traded around 0.86x price-to-book. Annuity insurers often trade at a discount because their GAAP earnings swing with markets and hedging, and investors discount the uncertainty in reported capital and future results.
How did JXN perform in 2025 and early 2026?
+
Adjusted operating earnings rose to about $1.6 billion, or roughly $22.67 per diluted share, in 2025, while GAAP net income to common shareholders was a small loss. Q1 2026 retail annuity sales of about $5.3 billion were up 31% year over year.
Walnut is informational and is not an investment adviser. This page is educational and not a recommendation to buy or sell JXN; figures are approximate and dated, and your own situation, time horizon, and risk tolerance should drive any decision. Verify current data before investing.